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Procathepsin L was purified to apparent homogeneity from the culture medium of v-Ha-ras transformed NIH3T3 (Ras-NIH) cells in three steps; 
anion-exchange chromatography, gel filtration, and re-gel filtration. SDS-PAGE analyses revealed that the purified samples contained only the 
precursor form, procathepsin L, but not the mature enzyme, cathepsin L. Antibodies against purified procathepsin L were raised. These recognized 
both rat cathepsin L and the purified procathepsin L. To isolate procathepsin L-specific antibodies that did not recognize cathepsin L, sequential 
affinity chromatography procedures were carried out. Immunoblot analyses howed that the procathepsin L-specific antibodies recognized only 
procathepsin L, but not cathepsin L. 
Procathepsin L; Cathepsin L; Procathepsin L-specific antibody 
1. INTRODUCTION 
Cathepsin L, a cysteine proteinase, is localized in ly- 
sosomes and participates in intracellular protein degra- 
dation [l]. The amino acid sequence of this enzyme has 
been determined at the protein level and deduced from 
the nucleotide sequence of its cDNA [2,3]. The amino 
acid sequence of cathepsin L is closely related to those 
of cathepsins B and H [4]; in contrast, the pro-peptide 
regions of those cysteine proteinases how less amino 
acid sequence similarity to one another [5]. A compari- 
son of the amino acid sequence determined at the pro- 
tein level and that deduced from the nucleotide sequence 
reveals that the cathepsin L gene is translated as prepro- 
cathepsin L, which is then processed to procathepsin L 
in the rough endoplasmic reticulum. Cathepsin L itself 
exists in lysosomes. Although these results are consis- 
tent with those obtained in pulse-chase analyses [6], the 
in situ location where procathepsin L is processed to 
cathepsin L remains unclear. 
Recently, procathepsin L was revealed to be identical 
to a major excreted protein (MEP) from NIH3T3 cells 
transformed by v-Ki-ras [7], a cyclic protein-2 secreted 
from sertoli cells [8], and a progesterone-dependent en- 
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dometrial secretory protein [9]. In addition, the expres- 
sion levels of the cathepsin L gene correlate closely with 
the metastatic potential of v-Ha-ras-transformed C3H- 
lOT1/2 cells in vivo [lo]. Thus, procathepsin L is se- 
creted both physiologically and pathologically. It is still 
unclear whether secreted procathepsin L acts as pro- 
cathepsin L or cathepsin L, to which procathepsin L is 
processed upon re-uptake into the cells. 
Antibodies against cathepsin L react with both 
cathepsin L and procathepsin L. Although these anti- 
bodies were able to reveal that cathepsin L is localized 
in lysosomes, they could not identify where the process- 
ing of procathepsin L occurs in situ. Some evidence 
suggests that lysosomal cysteine proteinases are proc- 
essed to the mature enzymes as soon as or before fusion 
of prelysosomes to endosomes, but it is still not known 
whether procathepsin L is processed to cathepsin L con- 
tinuously or during the uptake of extracellular materi- 
als. 
In this paper, we describe the purification of pro- 
cathepsin L and the generation of procathepsin L-spe- 
cific antibodies which do not react with the mature 
cathepsin L. These antibodies provide useful tools for 
answering the above questions and were used to estab- 
lish an ELISA system for measuring the levels of pro- 
cathepsin L in serum and extracellular fluids. 
2. MATERIALS AND METHODS 
Materials used in this work were obtained as follows: Sephadex 
G-75 and CNBr-activated Sepharose 4B from Pharmacia, DE-52 from 
Whatman, calf serum from United Biotechnologicals, nylon mem- 
branes (GV type) for immunoblot from Millipore, molecular weight 
size markers from Bio-Rad, horseradish peroxidase- and rhodamine- 
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conjugated anti-rabbit IgG from Cappel, horseradish peroxidase de- 
tection kits for immunoblot from Konika, membrane filters (YM-10) 
for ultrafiltration from Amicon, all others from Nakarai. 
Cathepsin L was purified from rat liver, and antibodies against rat 
cathepsin L were raised according to Bando et al. [1 11. Both NIH3T3 
and Ras-NIH cells, a generous gift from Dr. Michael Botchan [12], 
were cultured in DMEM supplemented with 5% bovine calf serum 
under a humidified 5% CO, atmosphere at 37’C. Ras-NIH cells were 
grown under subconfluent conditions, washed three times with 
PBS(-), and maintained in DMEM for 24 h. The medium was then 
concentrated by ultrafiltration using a membrane filter (YM-10) and 
dialyzed against 10 mM Tris-HCl (pH 7.5). This was then used as the 
starting material for the purification of procathepsin L. 
All procedures in the purification of procathepsin L were carried 
out at 4°C. The samples were subjected to anion-exchange chromatog- 
raphy on a DE-52 column equilibrated with 10 mM Tris-HCl (PH 7.5). 
The column was first washed with 30 column bed ~01s. of the equilibra- 
tion buffer, and then fractions containing procathepsin L were eluted 
with 30 column ~01s. of 10 mM Tris-HCl (pH 7.5) containing 100 mM 
NaCl. After concentration with a membrane filter (YM-IO), the sam- 
ples were applied to a Sephadex G-75 gel filtration column equili- 
brated and eluted with 10 mM Tris-HCl (pH 7.5), 150 mM NaCl at 
a flow rate of 6 ml/h. Aliquots from each fraction were subjected to 
SDS-PAGE and immunoblot analyses with anti-rat cathepsin L anti- 
bodies to identify the fractions containing procathepsin L [13,14]. 
Positive fractions were concentrated by ultrafiltration using the same 
membrane filter (YM-IO), and the samples were again subjected to gel 
filtration on Sephadex G-75 under the same conditions as the first gel 
filtration. 
Antibodies against purified procathepsin L were raised in rabbits 
by injecting the puriIied protein by emulsifying with an equal vol. of 
Freund’s complete adjuvant three times intracutaneously at 1 week 
intervals. Bleedings were carried out at 1 week intervals beginning 10 
days after the final immunization. The crude antibody fraction was 
obtained by two cycles of ammonium sulfate precipitation (40% and 
35% saturation), dialyzed against 50 mM sodium phosphate buffer 
(pH 7.0) containing 0.5 M NaCI, and applied to cathepsin L-Sepha- 
rose prepared by coupling purified rat cathepsin L to CNBr-activated 
Sepharose 4B in accordance with the manufacturer’s protocol. The 
column was washed with 30 column ~01s. of 50 mM sodium phosphate 
buffer (pH 7.0), containing 0.5 M NaCl, and the antibodies bound to 
cathepsin L-Sepharose were eluted with 3 mM HCI. Immediately, the 
fractions were neutralized with 2 ~01s. of 0.5 M sodium phosphate 
buffer (pH 7.0). Immunotinity chromatography was repeated until 
antibodies against cathepsin L were no longer eluted. After the pass- 
through fraction adsorbed to the cathepsin L-Sepharose five more 
times, the remainder was applied to procathepsin L-Sepharose. Anti- 
bodies bound to this column were obtained as mentioned above. 
Purified rat cathepsin L and mouse procathepsin L were electro- 
phoresed in 10% SDS-gels and followed by immunoblot analyses using 
the antibodies purified with cathepsin LSepharose, or with pro- 
cathepsin LSepharose after cathepsin L-Sepharose treatment. Anti- 
bodies bound to cathepsin L or procathepsin L were detected by 
horseradish peroxidaseconjugated anti-rabbit IgG and visualized 
using Konica Immunostaining kits. 
For fluorescence immunocytochemistry, NIH3T3 cells were fixed 
with 3% formaldehyde, permeabilized with PBS(-) containing 0.5% 
Triton X-100, and incubated with either anti-cathepsin L antibodies 
or anti-procathepsin L-specific antibodies. After incubation with 
rhodamine-conjugated anti-rabbit IgG, samples were examined using 
Zeiss Axiophot with a No. 15 filter. 
3. RESULTS AND DISCUSSION 
3.1. Pu@ication of procathepsin L 
Cathepsin L has been purified from various tissues 
and cells, including liver, kidney, brain, primary cul- 
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tured sertoli cells, and flushings of the uterus [1,2,8,9]. 
Although the ratio of cathepsin L to procathepsin L 
varied, these starting materials all contained both 
cathepsin L and procathepsin L. To purify only pro- 
cathepsin L, we chose culture medium without serum of 
Ras-NIH cells as the starting material. Ras-NIH cells 
secrete large amounts of procathepsin L, but no cathep- 
sin L, and can be maintained in serum-free medium for 
more than 24 h. 
Since procathepsin L is autocatalytically processed to 
cathepsin L under acidic conditions [ 151, all procedures 
in the purification of procathepsin L should be carried 
out above pH 7.0. The purification procedure we util- 
ized in this study consists of only three steps: anion- 
exchange chromatography (DE-52), gel filtration (Se- 
phadex G-75) and re-gel filtration (Sephadex G-75). 
Anion-exchange chromatography effectively removes 
procathepsin L from other proteins. A representative 
gel filtration profile from the first Sephadex G-75 col- 
umn is shown in Fig. 1. The fractions containing pro- 
cathepsin L (fraction numbers 4448) were identified by 
SDS-PAGE and followed by immunoblot analyses with 
anti-rat cathepsin L antibodies (data not shown). The 
fractions were combined, concentrated on a membrane 
filter (YM-lo), and subjected to the second gel filtration 
step. The fractions containing procathepsin L were 
combined and concentrated by ultrafiltration on a 
membrane filter (YM-10). Fig. 2 shows that procathep- 
sin L was purified to apparent homogeneity. From the 
starting material in 30 dishes (10 cm diameter), 200 pg 
of procathepsin L was isolated. Con A Sepharose, 
which has been used many times in previous studies, 
could not be utilized in this study for the following 
reasons. First, the Con A that co-elutes from Con A- 
Sepharose could not be separated from procathepsin L 
under neutral conditions by various chromatographic 
procedures, including anion-exchange chromatography 
and gel filtration. Second, the molecular weight of Con 
A is 29 kDa, close to that of cathepsin L; thus, any 
autoprocessed cathepsin L present could not be distin- 
guished from Con A. Third, if purified procathepsin L 
contaminated with even a small amount of Con A was 
used to immunize rabbits, antibodies against Con A 
would probably be raised in larger amounts than those 
against procathepsin L. 
3.2. Generation of procathepsin L-speciJic antibodies 
Initially, we tried to raise procathepsin L antibodies 
by immunizing rabbits with synthetic peptides prepared 
according to the amino acid sequence of the pro-peptide 
region deduced from its nucleotide sequence. This strat- 
egy was unsuccessful, probably because of the poor 
antigenic properties of the peptides. Therefore, we at- 
tempted to purify procathepsin L away from cathepsin 
L and use it to raise antibodies recognizing procathep- 
sin L but not cathepsin L. 
Immunoblot analyses carried out with affinity puri- 
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Fig. 1. Gel filtration profiles and SDS-PAGE analyses of procathepsin L purification. The samples eluted from anion-exchange chromatography 
(DE-52) with 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, and concentrated by ultrafiltration were subjected to gel filtration on Sephadex G-75. 
The chromatographic profile is shown at the top with the protein concentration measured at 280 nm plotted on the ordinate vs. fraction number 
on the abscissa. Aliquots of each fraction were subjected to SDS-PAGE in 12.5% gels. The lower panel shows the SDS-PAGE gel visualized by 
silver staining. The numbers above the gel indicate the fraction number from the gel filtration column. Arrows to the left of the gel indicate molecular 
weight markers: phosphorylase B, 97.4 kDa; bovine serum albumin, 66.0 kDa; ovalbumin, 45.0 kDa; carbonic anhydrase, 31 .O kDa; soybean trypsin 
inhibitor, 21.5 kDa; and lysozyme, 14.4 kDa. 
fied anti-cathepsin L antibodies and anti-procathepsin 
L-specific antibodies are shown in Fig. 3. Antibodies 
purified with cathepsin L-Sepharose recognized both 
rat cathepsin L and the purified procathepsin L (Fig. 3A 
and B). In contrast, the procathepsin L-specific anti- 
bodies purified with procathepsin L-Sepharose from 
the flow-through fraction from cathepsin L-Sepharose 
recognized only the purified procathepsin L, not rat 
cathepsin L (Fig. 3C and D). Since the amino acid se- 
quence of rat cathepsin L shares 97.7% identity to that 
of mouse cathepsin L [2,3], we used rat cathepsin L 
rather than mouse cathepsin L in this study. The pro- 
cathepsin L-specific antibodies recognized the non-de- 
natured procathepsin L because they bound to pro- 
cathepsin L-Sepharose. In addition, they also recog- 
nized denatured procathepsin L, as is apparent from 
their use in the immunoblot analyses (Fig. 3C and D) 
and fluorescence immunocytochemistry (data not 
shown). Thus, the procathepsin L-specific antibodies 
probably recognize both the amino acid sequence of the 
propeptide region and the three-dimensional structure 
of procathepsin L, although their epitopes have not 
been identified. 
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Fig. 2. SDS-PAGE analyses of the purified procathepsin L. Either 1 
pg (lane 1) or 0.2 pg (lane 2) of the purified procathepsin L was 
analyzed by 10.0% SDS-PAGE and the gels were stained with 
Coomassie brilliant blue R-250. Arrowheads on the left indicate the 
molecular weight markers described in the legend to Fig. 1. Purified 
procathepsin L migrated as 35 kDa. 
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Fig. 3. Immunoblot analyses with antibodies purified with cathepsin L-Sepharose or procathepsin L-specific antibodies. Rat cathepsin L (lanes 
1) and purified procathepsin L (lanes 2) were subjected to 10% SDS-PAGE and the proteins were transferred to the nylon membranes. The 
membranes were blocked with 5% non-fat dried milk in TBS (w/v), and immersed with 0.5 &ml (A) or 2.5 &ml (B) of the antibodies purified 
with cathepsin LSepharose or with 0.5 &ml (C) or 2.5 &ml (D) of the procathepsin L-specific antibodies (see text for details). Bound antibodies 
were detected with horseradish peroxidase-conjugated anti-rabbit IgG, and visualized using Konica immunostaining kits. Arrowheads (A) and (B) 
indicate cathepsin L and the purified procathepsin L, respectively. 
Primary structure and pulse-chase studies have re- 
vealed that cathepsin L is translateabd as preprocathep- 
sin L and processed into cathepsin L via procathepsin 
L [24]. However, the in situ location where procathep- 
sin L is processed to cathepsin L has not been identified. 
Additionally, in vitro investigation has revealed that 
procathepsin L is autocatalytically processed to cathep- 
sin L at pH’s below 5.0, but there are no intracellular 
compartments this acidic [I 51. Recently, it was found 
that when procathepsin L was incubated with dextran. 
it was processed into cathepsin L at a higher pH than 
when dextran was omitted [16]. If the processing of 
procathepsin L requires that materials be endocytosed, 
then the processing of the procathepsin L might occur 
after the fusion of the prelysosome to the endosome. 
Electron microscopic studies using our procathepsin L- 
specific antibodies could verify the above hypothesis. 
Procathepsin L is secreted from endometrial cells, 
sertoli cells, and v-Ki-ras-transformed NIH3T3 cells [7- 
9]. The roles of secreted procathepsin L are unclear, but 
are probably related to the amount present under vari- 
ous conditions. If this is the case, then it is important 
to measure the amounts of secreted procathepsin L. It 
would be possible to measure the amounts of secreted 
procathepsin L in serum and extracellular fluids by an 
ELISA system which could be established using both 
anti-cathepsin L- and anti-procathepsin L-specific anti- 
bodies. 
We have described the purification of procathepsin L
from the medium of Ras-NIH cells, and isolated pro- 
cathepsin L-specific antibodies from anti-sera against 
procathepsin L by sequential immunoaffinity purifica- 
tion techniques. 
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